Acute Myeloid Leukemia-AML
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood and bone marrow, affecting myeloid cells.
Patients may experience fatigue, infections, easy bruising, and abnormal bleeding. Early diagnosis via blood tests, bone marrow biopsy, and cytogenetic analysis is essential for prompt treatment through chemotherapy, targeted therapy, or stem cell transplantation.
Causes and Risk Factors of Acute Myeloid Leukemia
AML arises due to genetic mutations and environmental exposures affecting myeloid precursor cells.
- Genetic predisposition: Certain mutations and inherited syndromes increase risk.
- Exposure to chemotherapy or radiation
- Age and lifestyle factors: Most common in adults over 60; smoking and chemical exposures may contribute.
Symptoms and Clinical Features
AML symptoms result from reduced normal blood cells.
- Fatigue and weakness
- Frequent infections: Due to low white blood cell count
- Easy bruising or bleeding, including gums and nose
- Fever and night sweats
Treatment Modalities for Acute Myeloid Leukemia
Treatment aims to eradicate leukemic cells and restore normal blood cell production.
- Chemotherapy: Standard induction and consolidation therapy.
- Stem cell transplantation: For eligible patients to achieve long-term remission.
- Targeted therapy and supportive care as needed.
Why Choose Us for Acute Myeloid Leukemia
CureU Healthcare provides expert hematology-oncology care, modern diagnostic tools, and personalized treatment plans to manage AML effectively.
Conclusion
Acute Myeloid Leukemia is an aggressive but treatable blood cancer with timely intervention. CureU Healthcare ensures comprehensive and multidisciplinary care for optimal outcomes.
